How to Analyze Array CGH
Array CGH Reference: Barrett M.T. (2004)

     Using for dye normalization by using the locally weighted linear-regression curve except that probes from autosomal chromosomes to fit option. Also, we used signals from negative control features for background subtraction.

     The expression array design involved 10 replicate features for a subset of 100 probes. Each probe has replicate features, the mean and standard deviation of background-subtracted signals was calculated in both channels independently after the elimination of outliers. Outlier feature rejection was based on limits of 1.5 intraquartile ranges from the median.

 

     We applied three filtering procedures to our expression array data sets.

First, 97 of the 17,086 probes were removed from our analyses (because they had mean signals in the reference channel of less than three standard deviations above the mean of the negative control feature signals in at least three of five hybridizations).

Second, to remove probes that cross mRNA splice boundaries, we removed the 755 probes (because they had not contiguous in the genome).

Last, all expression-array probes were screened for homology against the whole human genome. We removed 5,175 probes that, although unique in the transcriptome, gave more than one hit in the genome and were removed subsequently from our analyses. This filter excluded probes with even as many as 19 mismatches to a second homologous site.

     A total of 11,072 probes on the expression arrays satisfied all three filtering criteria.

     Nowadays has many methods could compare and analyze the array CGH:

1). Metaphase fluorescence images 2). Metaphase monochrome camera images, 3). Karyogram fluorescence images, 4). Karyogram monochrome images, 5). CGH Sum Karyogram (FITC/TRITC Ratio), 6). CGH Super Karyogram

History
Introduction to Array CGH
Compare
Content
Example
Reference website
Reference theses
Home

       Not apply any filters to the CGH array data sets. However, given the high density of probes per chromosome on the CGH arrays, visual interpretation of known genomic lesions in plots of raw data are unclear by even a small percentage of outlier probes. Hence, we applied a 50-kb moving average, as calculated below, to plots presented in Figs. 4–6. Smoothing: The log2 ratio measured for all m probes of the chromosome by using the following weighted moving average.

    fomula1fomula2

yi is the measured log2 ratio at xi (formula 1). Triangular function (formula 2).

xi is the chromosomal position (in bases) of probe i.

W is the half width of the triangular function.

       To explore error modeling of aCGH data, the colorcoded points in CGH array plots by using the following method. The variance of each smoothed point is estimated as follows:

                                      fomula3

      σ is the standard deviation of the log2 ratio for each set of chromosome-specific probes on the CGH array in a series of hybridizations with cell lines that are diploid for the entire chromosome under investigation.

       In each example, probes with log2 ratios >  are expressed in red (increase in copy number), probes with log2 ratios < are expressed in green (decrease in copy number), and no change probes are shown in blue. 

                                     

      To use the expression array to measure copy-number changes in four well characterized tumor cell lines (COLO 320DM, HT 29, MDA-MB-231, and MDA-MB-453) with chromosomal abnormalities. The lesions catch in the tumor cells include a high-level (log2 ratio = 6.4) amplification of MYC in COLO 320DM and an amplicon spanning 8q23.1–24.23 with a 3-fold (log2 ratio = 1.5) increase in the copy number of MYC with simultaneous single-copy 8p deletion in HT 29 (Fig. 1).

                                                                                                                                              TOP

                                     fig1

                                                                                                                                               TOP

 

     To test oligonucleotide aCGH with in vivo material, we used the expression arrays to screen four soft-tissue sarcomas analyzed prior with cDNA aCGH. A compare method using a common build of the human genome to map probe positions demonstrated a striking similarity between the cDNA and oaCGH profiles (Fig. 2).

fig2

                                                                                                                                               TOP

      The reference 46,XX DNA which the initial measurement of the performance of arrays was done with hybridizations of genomic DNA samples from a series of cell lines with variable copy numbers of the X chromosome.

      The comparison of the median ratios for the X-chromosome probes from these hybridizations on the expression array (373 probes) and the CGH array (4,878 probes) showed that the correlation coefficients were 0.98 and 0.99, respectively, and the slope increased from 0.47 to 0.96 (Fig. 3).

 

      The median ratio values on aCGH of the X-chromosome probes in these data were 0.5 for XY_XX, 1.0 for XX_XX, 1.4 for XXX_XX, 2.1 for XXXX_XX, and 2.6 for XXXXX_XX (Fig. 3 C and D). These data are in the closest agreement with the ideal values of 0.5, 1.0, 1.5, 2.0, and 2.5 reported for aCGH. These data highlight with the usefulness of designing and selecting in situ synthesized oligonucleotide probes for aCGH assays.

fig3

                                                                                                                                              TOP

       Examined the 3,293 probes on these arrays representing unique genomic sequences at an average spacing of 23 kb along chromosome 18 in the 18q-syndrome patient-derived cell line GM50122 to assess our ability to detect and map intrachromosomal single-copy losses. The single-copy loss on 18q was finded, and the breakpoint region was localized visually and numerically to the known genomic location by using a moving average of 50 kb and noise model for chromosome 18 (Fig. 4).

                                    fig4

                                                                                                                                              TOP

       To detect the single-copy losses, tumor cells may contain homozygous deletions that target specific genes. Using the HCT116 colon carcinoma cells as a model system to assess our ability to detect and map homozygous deletions by using the aCGH. These cells include two known homozygous deletions on chromosome 16 that include the A2BP1 gene (16p13.2) and the FRA16D locus (16q23.2).

 

       First, of these homozygous deletions was detected by BAC aCGH.

Second, homozygous deletion (16q) was characterized by positional cloning. Only loci with probes on these arrays which measured log2 ratios were below a theoretical threshold of -2 in replicate experiments were 16p13.2 (nine probes) and 16q23.2 (two probes) (Fig. 5).

                                    fig5

                                                                                                                                              TOP

in vivo culture in the live body.

 

in vitro culture in the tube, like the animal and plant of the tissue culture.

 

ex vitro relative with the in vitro. It means the advance work after the tube culture leave.